Achilles Therapeutics

NASDAQ: ACHL · Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM

Achilles Therapeutics Statistics

Share Statistics

Achilles Therapeutics has 41.1M shares outstanding. The number of shares has increased by 0.03% in one year.

41.1M
0.03%
0%
60.1%
n/a
5,471
0.43%

Short Selling Information

n/a
n/a
n/a
n/a

Valuation Ratios

The PE ratio is -0.51 and the forward PE ratio is null. Achilles Therapeutics's PEG ratio is 0.12.

-0.51
n/a
0
n/a
0.25
-0.72
0.12
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Achilles Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 8.57, with a Debt / Equity ratio of 0.03.

8.57
8.57
0.03
-0.07
-0.09
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-341,495.1
204
0
4.73M

Taxes

491K
-0.71%

Stock Price Statistics

The stock price has increased by 88.82% in the last 52 weeks. The beta is 1.25, so Achilles Therapeutics's price volatility has been higher than the market average.

1.25
88.82%
1.32
1.02
76.37
1,281,745

Income Statement

n/a
-4.73M
-75.25M
-69.67M
-70.44M
-75.16M
-1.74
Full Income Statement

Balance Sheet

The company has 131.54M in cash and 4.62M in debt, giving a net cash position of 126.92M.

131.54M
4.62M
126.92M
-259.95M
122.68M
93.16M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -48.45M and capital expenditures -1.1M, giving a free cash flow of -49.55M.

-48.45M
-1.1M
-49.55M
-1.24
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

ACHL does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ACHL is $4, which is 170.3% higher than the current price. The consensus rating is "Hold".

$4
170.3%
Hold
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-2.67
1